Packaging protein drugs as bacterial inclusion bodies for therapeutic applications
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Villaverde, A.; García-Fruitós, E.; Rinas, Ursula; Seras-Franzoso, J.; Kosoy, A. et al.: Packaging protein drugs as bacterial inclusion bodies for therapeutic applications. In: Microbial Cell Factories 11 (2012), 76. DOI: http://dx.doi.org/10.1186/1475-2859-11-76
- Ereignis
-
Veröffentlichung
- (wo)
-
Hannover
- (wer)
-
Gottfried Wilhelm Leibniz Universität Hannover
- (wann)
-
2012
- Ereignis
-
Veröffentlichung
- (wo)
-
Hannover
- (wer)
-
Technische Informationsbibliothek (TIB)
- (wann)
-
2012
- Urheber
-
Villaverde, Antonio
García-Fruitós, Elena
Rinas, Ursula
Seras-Franzoso, Joaquin
Kosoy, Ana
Corchero, Josè Luis
Vázquez, Esther
- DOI
-
10.15488/636
- URN
-
urn:nbn:de:101:1-2020080806330131208262
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Villaverde, Antonio
- García-Fruitós, Elena
- Rinas, Ursula
- Seras-Franzoso, Joaquin
- Kosoy, Ana
- Corchero, Josè Luis
- Vázquez, Esther
- Gottfried Wilhelm Leibniz Universität Hannover
- Technische Informationsbibliothek (TIB)
Entstanden
- 2012
Ähnliche Objekte (12)
Packaging protein drugs as bacterial inclusion bodies for therapeutic applications
Cellular toxicity triggered by bacterial inclusion bodies
Isolation of cell-free bacterial inclusion bodies
Learning about protein solubility from bacterial inclusion bodies
Bacterial inclusion bodies as potential synthetic devices for pathogen recognition and a therapeutic substance release
Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors
Isolation of biologically active nanomaterial (inclusion bodies) from bacterial cells
Protein aggregation into bacterial inclusion bodies is a specific kinetically driven process
Inclusion bodies: a new concept
Characterization of the amyloid bacterial inclusion bodies of the HET-s fungal prion
Recovery of bioactive protein from bacterial inclusion bodies using trifluoroethanol as solubilization agent
Aggregation as bacterial inclusion bodies does not imply inactivation of enzymes and fluorescent proteins
Packaging protein drugs as bacterial inclusion bodies for therapeutic applications
Cellular toxicity triggered by bacterial inclusion bodies
Isolation of cell-free bacterial inclusion bodies
Learning about protein solubility from bacterial inclusion bodies
Bacterial inclusion bodies as potential synthetic devices for pathogen recognition and a therapeutic substance release
Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors
Isolation of biologically active nanomaterial (inclusion bodies) from bacterial cells
Protein aggregation into bacterial inclusion bodies is a specific kinetically driven process
Inclusion bodies: a new concept
Characterization of the amyloid bacterial inclusion bodies of the HET-s fungal prion
Recovery of bioactive protein from bacterial inclusion bodies using trifluoroethanol as solubilization agent
Aggregation as bacterial inclusion bodies does not imply inactivation of enzymes and fluorescent proteins
Packaging protein drugs as bacterial inclusion bodies for therapeutic applications
Cellular toxicity triggered by bacterial inclusion bodies
Isolation of cell-free bacterial inclusion bodies
Learning about protein solubility from bacterial inclusion bodies
Bacterial inclusion bodies as potential synthetic devices for pathogen recognition and a therapeutic substance release
Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors
Isolation of biologically active nanomaterial (inclusion bodies) from bacterial cells
Protein aggregation into bacterial inclusion bodies is a specific kinetically driven process
Inclusion bodies: a new concept
Characterization of the amyloid bacterial inclusion bodies of the HET-s fungal prion
Recovery of bioactive protein from bacterial inclusion bodies using trifluoroethanol as solubilization agent